Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Thyroid NeoplasiaWell-Differentiated Thyroid CancerMedullary Thyroid CancerLymph Node Metastases
Interventions
DEVICE

Laser ablation

Single session with Diode laser ablation system; one or two applicators will be used for treatments; one to three illuminations; fixed output power of 3 watts (W); pullback technique; delivered energy: 1200-1800 Joules (J) varying according to tumor volume; treatment under local anesthesia +- conscious or moderate sedation;

DEVICE

Cryoablation

Single session with Argon-based cryoablation system; one 17 Gauge (G) V-probe applicator will be used for treatments; fixed gas delivery of 100%; treatment under local anesthesia +- conscious or moderate sedation;

DEVICE

Radiofrequency ablation

Single session with radiofrequency generator; one 17 Gauge (G) V-tip applicator with a 1 to 4cm active tip; moving-shot technique or multiple overlapping shot technique with 60 Watts (W) output power; treatment under local anesthesia +- conscious or moderate sedation;

Trial Locations (1)

01246000

Instituto do Cancer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER